期刊
MULTIPLE SCLEROSIS JOURNAL
卷 21, 期 2, 页码 249-251出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1352458514528759
关键词
Fingolimod; multiple sclerosis; edema; steroid
The occurrence of macular edema as an adverse effect of fingolimod is well documented. Treatment modalities used to manage fingolimod-associated macular edema (FAME) have included nonsteroidal anti-inflammatory agents and sub-tenon injection. We describe two cases where intravitreal injection is used to successfully treat FAME in patients who were previously unsuccessfully treated with topical nonsteroidal anti-inflammatories.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据